B

    Brainsway Ltd (BWAY)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $14.52
    +0.22 (+1.54%)

    Market Cap: $574.70M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    80%(24/30)
    Avg Surprise
    +18.65%
    Streak
    14 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.07
    Range$0.07 - $0.07
    2 analysts
    EPS RevisionsNo revisions (7d)
    1
    1
    30d
    EPS Estimate Drift
    90d ago$0.06-14.3%
    60d ago$0.09+23.9%
    30d ago$0.10+35.7%
    7d ago$0.09+23.9%
    Current$0.07
    Revenue Consensus
    $18M
    Range$17M - $18M
    3 analysts
    Dec 31, 2026
    EPS Consensus$0.08
    Range$0.08 - $0.08
    2 analysts
    Revenue Consensus
    $20M
    Range$20M - $20M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.08---
    Sep 26EST
    		-$0.07---
    Jun 26
    		$0.14$0.10+40.00%Beat+366.7%
    Mar 26
    		$0.06$0.05+20.00%Beat+500.0%
    Dec 25
    		$0.06$0.05+39.91%Beat+59.5%
    Sep 25
    		$0.02$0.02+0.00%Beat+100.0%
    Jun 25
    		$0.03$0.02+50.00%Beat+200.0%
    Mar 25
    		$0.01$0.01+0.00%Beat+49.3%
    Dec 24
    		$0.04$0.02+100.00%Beat+426.3%
    Sep 24
    		$0.01$0.01+0.00%Beat+150.0%
    Jun 24
    		$0.01$-0.01+200.00%Beat+150.0%
    Mar 24
    		$0.01$-0.01+167.00%Beat+116.8%
    Dec 23
    		$0.01$-0.01+176.00%Beat+103.2%
    Sep 23
    		$-0.02$-0.02+0.00%Beat+71.4%
    Jun 23
    		$-0.02$-0.04+50.00%Beat+50.0%
    Mar 23
    		$-0.04$-0.05+20.00%Beat-33.3%
    Dec 22
    		$-0.24$-0.13-84.62%Miss-500.0%
    Sep 22
    		$-0.07$-0.03-133.33%Miss-250.0%
    Jun 22
    		$-0.04$-0.03-33.33%Miss-33.3%
    Mar 22
    		$-0.03$-0.04+25.00%Beat+40.0%
    Dec 21
    		$-0.04$-0.05+20.00%Beat+0.0%
    Sep 21
    		$-0.02$-0.03+33.33%Beat+0.0%
    Jun 21
    		$-0.03$-0.03+0.00%Beat-200.0%
    Mar 21
    		$-0.05$-0.03-66.67%Miss+83.3%
    Dec 20
    		$-0.04$-0.07+42.86%Beat+20.0%
    Sep 20
    		$-0.02$-0.03+33.33%Beat+83.3%
    Jun 20
    		$-0.01N/A+83.33%Beat+97.1%
    Mar 20
    		$-0.30$-0.15-100.00%Miss-172.7%
    Dec 19
    		$-0.05$-0.06+16.67%Beat+58.3%
    Sep 19
    		$-0.12$-0.12+0.00%Beat-35.1%
    Jun 19
    		$-0.34$-0.13-161.54%Miss-209.9%
    Mar 19
    		$-0.11$-0.14+21.43%Beat-78.3%
    Dec 18
    		$-0.12$0.00N/AMiss+28.4%
    Sep 18
    		$-0.09N/AN/ABeat+28.6%
    Jun 18
    		$-0.11N/AN/ABeat-216.1%
    Mar 18
    		$-0.06N/AN/ABeat+52.9%
    Dec 17
    		$-0.17N/AN/ABeat-63.6%
    Sep 17
    		$-0.12N/AN/ABeat-180.8%
    Jun 17
    		$-0.03N/AN/ABeat-
    Mar 17
    		$-0.13N/AN/ABeat-
    Dec 16
    		$-0.10N/AN/ABeat-
    Sep 16
    		$-0.04N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio51.16EV/EBITDA44.12x
    Price/FCF65.90xFCF Yield1.52%
    Profitability
    Profit Margin15.60%Operating Margin14.00%
    ROE12.80%ROIC12.83%
    Financial Health
    Debt/Equity0.02xInterest Coverage4.74x
    Current Ratio3.59xQuick Ratio3.27x
    Trading Statistics
    Beta0.10Avg Volume123.74K
    52-Week High$17.4052-Week Low$7.13

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$14.57
    SMA 20$15.14
    SMA 50$15.19
    SMA 200$13.14
    EMA 10$14.65
    EMA 20$14.93
    EMA 50$15.09
    EMA 200$13.18

    MACD

    Line: -0.29Signal: -0.17Hist: -0.11

    ADX

    ADX: 12.5+DI: 16.9-DI: 23.1

    Aroon & PSAR

    Aroon Up48.0
    Aroon Down88.0
    PSAR$16.89

    Bollinger Bands

    Upper Band$16.63
    Lower Band$13.66
    %B Position1963%(Upper)
    Band Width0.29

    RSI (14-Day)

    Neutral
    44.9

    Momentum Oscillators

    Stoch %K11.4
    Stoch %D10.2
    Williams %R-85.2
    ROC (10d)-6.3%
    Momentum-0.97
    CCI (20d)-80.7
    MFI (14d)62.0

    Volatility Measures

    ATR (14d)$0.74(5.1%)
    StdDev (20d)0.74
    Hist Vol58.5%(High)

    Volume Flow

    VWAP$14.46
    OBV2.6M
    AD Line-355.0M
    CMF (20d)-0.142

    Volume Metrics

    Avg Vol (20d)125.6K
    Vol Ratio0.6x
    VWMA (20d)$15.60

    Pivot Points

    R3$15.20
    R2$14.93
    R1$14.62
    Pivot Point$14.35
    S1$14.04
    S2$13.77
    S3$13.46

    Advanced Oscillators

    TSI-9.24
    Ultimate Osc41.4
    KST-41.43

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$17.40M$15.53M$14.54M$13.51M$12.63M$11.54M$11.41M$10.50M$10.01M$9.10M$9.03M$8.30M
    Cost of Revenue$4.42M$3.86M$3.43M$3.35M$3.13M$2.93M$2.90M$2.78M$2.47M$2.28M$2.29M$2.13M
    Gross Profit$12.99M$11.68M$11.12M$10.16M$9.50M$8.61M$8.51M$7.72M$7.54M$6.81M$6.74M$6.17M
    Operating Expenses$10.55M$9.67M$9.20M$8.91M$8.92M$8.03M$8.08M$7.44M$6.95M$6.72M$-3,363,000$6.30M
    R&D$3.27M$2.88M$2.53M$2.40M$2.34M$2.33M$2.04M$1.81M$1.71M$1.63M$1.43M$1.54M
    SG&A$0$1.86M$1.57M$1.78M$1.64M$1.54M$1.56M$1.52M$1.44M$1.27M$11.56M$1.16M
    Operating Income$2.43M$2.00M$1.92M$1.25M$578,000$576,000$431,000$281,000$586,000$93,000$10.10M$-133,000
    Interest Income$0$724,000$1.06M$1.13M$2.30M$1.27M$532,000$830,000$518,000$618,000$0$175,000
    Interest Expense$894,093$319,000$433,692$571,000$784,000$586,000$1.05M$374,000$401,000$428,000$160,000$213,000
    Income Before Tax$2.97M$2.41M$2.54M$1.81M$2.10M$1.26M$1.74M$737,000$703,000$283,000$-37,000$-171,000
    Income Tax Expense$211,571$120,000$-392,000$242,000$70,000$157,000$188,000$75,000$103,000$172,000$-164,000$59,000
    Net Income$2.76M$2.29M$2.93M$1.57M$2.03M$1.11M$1.55M$662,000$600,000$111,000$127,000$-230,000
    EBITDA$2.88M$3.19M$3.32M$2.78M$3.27M$2.24M$1.07M$1.56M$1.40M$1.03M$1.58M$374,000
    EBIT$2.43M$2.73M$2.97M$2.38M$2.88M$1.85M$431,000$1.11M$1.10M$711,000$1.25M$42,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about BWAY

    News

    Brainsway (NASDAQ:BWAY) Shares Down 5.3% - Here's Why

    Brainsway (NASDAQ:BWAY) shares dropped 5.3% in light trading, closing at $15.4560, despite the company exceeding quarterly expectations with $0.14 EPS and $17.11 million in revenue. Analysts maintain a "Moderate Buy" consensus rating with an average price target of $16.95, with some firms like BTIG raising their target to $20. Institutional investors have also adjusted their holdings in the medical device company.

    MarketBeat•8/17/26•
    Neutral

    Brainsway (BWAY) Upgraded to Buy: Here's Why

    Brainsway Ltd. Sponsored ADR (BWAY) has been upgraded to a Zacks Rank #2 (Buy), indicating an upward trend in its earnings estimates. This upgrade suggests positivity about the company's earnings outlook, which could lead to increased stock price due to institutional investor interest in improving business trends. The Zacks Rank system, which correlates earnings estimate revisions with stock price movements, positions BWAY in the top 20% of Zacks-covered stocks.

    Yahoo! Finance Canada•8/17/26•
    Bullish

    Trading the Move, Not the Narrative: (BWAY) Edition

    This article provides an AI-generated analysis of Brainsway Ltd. (NASDAQ: BWAY), highlighting a near-term strong sentiment despite neutral mid and long-term outlooks. It details specific trading strategies for different risk profiles, including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis and support/resistance levels. The analysis emphasizes an exceptional 88.4:1 risk-reward setup targeting a 27.4% gain versus 0.3% risk.

    Stock Traders Daily•8/15/26•
    Somewhat-Bullish

    Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Receives Consensus Rating of "Moderate Buy" from Analysts

    Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) has received a consensus "Moderate Buy" rating from analysts, with an average 12-month price target of $16.95, though BTIG recently raised its target to $20. The company reported record quarterly revenue of $17.1 million, a 35% year-over-year increase, and raised its 2026 revenue outlook to $68 million–$70 million. Despite a recent downgrade from Zacks Research to "hold," institutional investors own about 30.11% of the stock, which is trading near its 52-week high.

    MarketBeat•8/14/26•
    Somewhat-Bullish

    BrainsWay: Market Saturation And Competition Could Be Issues (NASDAQ:BWAY)

    BrainsWay delivered strong Q2 financial results with 35% YoY revenue growth and margin expansion, fueled by market expansion. However, the company's valuation is considered high, raising concerns about future competition from psychedelics and potential market saturation. While near-term momentum is possible, sustained long-term growth is uncertain without successful expansion into new indications or strategic acquisitions.

    Seeking Alpha•8/13/26•
    Somewhat-Bearish

    Frequently Asked Questions About BWAY

    Does BWAY pay dividends?
    Brainsway Ltd (BWAY) does not currently pay a regular dividend.
    What is BWAY's P/E ratio?
    Brainsway Ltd has a price-to-earnings (P/E) ratio of 51.16.
    What is BWAY's market cap?
    Brainsway Ltd (BWAY) has a market capitalization of $574.70M with a current stock price of $14.52.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In